GWM
ELAN icon

Geneos Wealth Management’s Elanco Animal Health ELAN Stock Holding History

Geneos Wealth Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.11M Buy
207,575
+4,828
+2% +$112K 0.1% 222
2026
Q1 		$4.85M Buy
202,747
+196,884
+3,358% +$4.81M 0.11% 209
2025
Q4 		$133K Sell
5,863
-50
-0.8% -$1.09K ﹤0.01% 1067
2025
Q3 		$119K Sell
5,913
-41
-0.7% -$687 ﹤0.01% 1068
2025
Q2 		$85K Buy
5,954
+2,080
+54% +$24.3K ﹤0.01% 1314
2025
Q1 		$40.7K Sell
3,874
-79
-2% -$894 ﹤0.01% 1597
2024
Q4 		$47.9K Sell
3,953
-71
-2% -$929 ﹤0.01% 1339
2024
Q3 		$59.1K Buy
4,024
+217
+6% +$3.02K ﹤0.01% 1139
2024
Q2 		$54.9K Sell
3,807
-530
-12% -$8.47K ﹤0.01% 1037
2024
Q1 		$70.6K Sell
4,337
-1,134
-21% -$17.7K ﹤0.01% 957
2023
Q4 		$81.5K Sell
5,471
-6,016
-52% -$68.1K ﹤0.01% 896
2023
Q3 		$129K Sell
11,487
-6,183
-35% -$71.8K 0.01% 799
2023
Q2 		$178K Sell
17,670
-5,584
-24% -$51.8K 0.01% 705
2023
Q1 		$219K Sell
23,254
-5,053
-18% -$59.6K 0.01% 634
2022
Q4 		$346K Buy
28,307
+7,154
+34% +$89.2K 0.02% 488
2022
Q3 		$262K Buy
21,153
+8,173
+63% +$143K 0.02% 540
2022
Q2 		$267K Buy
12,980
+1,103
+9% +$26.1K 0.01% 649
2022
Q1 		$309K Buy
11,877
+1,972
+20% +$52.5K 0.01% 658
2021
Q4 		$281K Buy
9,905
+865
+10% +$26.9K 0.01% 748
2021
Q3 		$290K Buy
9,040
+5,149
+132% +$173K 0.01% 728
2021
Q2 		$135K Buy
3,891
+639
+20% +$21.1K 0.01% 1031
2021
Q1 		$103K Buy
+3,252
New +$100K ﹤0.01% 1297
2020
Q3 		– Sell
-67
Closed -$1K – 2648
2020
Q2 		$1K Sell
67
-2,894
-98% -$63.9K ﹤0.01% 2451
2020
Q1 		$64K Buy
2,961
+157
+6% +$4.3K ﹤0.01% 1021
2019
Q4 		$82K Buy
2,804
+2,737
+4,085% +$74.4K ﹤0.01% 1028
2019
Q3 		$1K Sell
67
-1,072
-94% -$32.2K ﹤0.01% 2390
2019
Q2 		$38K Buy
1,139
+1,000
+719% +$32.5K ﹤0.01% 1329
2019
Q1 		$4K Buy
+139
New +$4.28K ﹤0.01% 2083

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Geneos Wealth Management's ELAN Position: Q2 2026 in Review

Geneos Wealth Management increased its Elanco Animal Health (ELAN) stake by 2.4% in Q2 2026, buying an estimated $112K and bringing the position to 207,575 shares worth $5.11M. The position accounts for 0.1% of the portfolio, ranked #222.

Geneos Wealth Management first reported a position in ELAN in Q1 2019 and has held it in 28 quarters since. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Geneos Wealth Management held 207,575 shares of Elanco Animal Health worth $5.11M as of Q2 2026.
  • Geneos Wealth Management bought 4,828 Elanco Animal Health shares in Q2 2026, an estimated $112K.
  • Elanco Animal Health made up 0.1% of Geneos Wealth Management's portfolio in Q2 2026, its #222 holding.
  • Geneos Wealth Management first reported a position in Elanco Animal Health in Q1 2019 and has held it in 28 quarters since.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.